Publication | Closed Access

Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine/busulfan

Non-relapse MortalityTransplantationMarrow TransplantationStem Cell TransplantationHematologyImmunologyAcute Graft-versus-host DiseaseBlood TransplantationImmunotherapyMedicineCell TransplantationHigher IncidenceGraft Rejection